The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Myeloid-derived Suppressor Cells Are Necessary for Development of Pulmonary Hypertension
Open accessAbstract
Pulmonary hypertension (PH) complicates the care of patients with chronic lung disease, such as idiopathic pulmonary fibrosis (IPF), resulting in a significant increase in morbidity and mortality. Disease pathogenesis is orchestrated by unidentified myeloid-derived cells. We used murine models of PH and pulmonary fibrosis to study the role of circulating myeloid cells in disease pathogenesis and prevention. We administered clodronate liposomes to bleomycin-treated wild-type mice to induce pulmonary fibrosis and PH with a resulting increase in circulating bone marrow–derived cells. We discovered that a population of C-X-C motif chemokine receptor (CXCR) 2+ myeloid-derived suppressor cells (MDSCs), granulocytic subset (G-MDSC), is associated with severe PH in mice. Pulmonary pressures worsened despite improvement in bleomycin-induced pulmonary fibrosis. PH was attenuated by CXCR2 inhibition, with antagonist SB 225002, through decreasing G-MDSC recruitment to the lung. Molecular and cellular analysis of clinical patient samples confirmed a role for elevated MDSCs in IPF and IPF with PH. These data show that MDSCs play a key role in PH pathogenesis and that G-MDSC trafficking to the lung, through chemokine receptor CXCR2, increases development of PH in multiple murine models. Furthermore, we demonstrate pathology similar to the preclinical models in IPF with lung and blood samples from patients with PH, suggesting a potential role for CXCR2 inhibitor use in this patient population. These findings are significant, as there are currently no approved disease-specific therapies for patients with PH complicating IPF.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“preventing their recruitment via neutralization of CXCR2 normalized the pulmonary pressure (119).”
From The Role of Immune and Inflammatory Cells in Idiopathic Pulmonary Fibrosis (2018) · cites this paper as [119]
Experimental — accuracy not yet measuredIn the citing paper
“Another experiment with bleomycin-induced mice showed that MDSCs triggered vascular remodeling and pulmonary hypertension”
From The Role of Immune and Inflammatory Cells in Idiopathic Pulmonary Fibrosis (2018) · cites this paper as [119]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
Bronte, V., Brandau, S., Chen, S.-H., Colombo, M. P., Frey, A. B., Greten, T. F., Mandruzzato, S., Murray, P. J., Ochoa, A., Ostrand-Rosenberg, S., et al. (2016) · Nature Communications · doi:10.1038/ncomms12150 · Cited by 2,751
Fulminant Myocarditis with Combination Immune Checkpoint Blockade
Johnson, D. B., Balko, J. M., Compton, M. L., Chalkias, S., Gorham, J., Xu, Y., Hicks, M., Puzanov, I., Alexander, M. R., Bloomer, T. L., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1609214 · Cited by 2,308
Myeloid-Derived Suppressor Cells
Gabrilovich, D. I. (2017) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-16-0297 · Cited by 1,882
Regulation of immune responses by L-arginine metabolism
Bronte, V., & Zanovello, P. (2005) · Nature Reviews Immunology · doi:10.1038/nri1668 · Cited by 1,775
Du, R., Lu, K. V., Petritsch, C., Liu, P., Ganss, R., Passegué, E., Song, H., VandenBerg, S., Johnson, R. S., Werb, Z., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.01.034 · Cited by 1,130
Prevalence and Outcomes of Pulmonary Arterial Hypertension in Advanced Idiopathic Pulmonary Fibrosis
Lettieri, C. J., Nathan, S. D., Barnett, S. D., Ahmad, S., & Shorr, A. F. (2006) · Chest · doi:10.1378/chest.129.3.746 · Cited by 879
Tumor-Induced Tolerance and Immune Suppression Depend on the C/EBPβ Transcription Factor
Marigo, I., Bosio, E., Solito, S., Mesa, C., Fernandez, A., Dolcetti, L., Ugel, S., Sonda, N., Bicciato, S., Falisi, E., et al. (2010) · Immunity · doi:10.1016/j.immuni.2010.05.010 · Cited by 850
Rodriguez, P. C., Ernstoff, M. S., Hernandez, C., Atkins, M., Zabaleta, J., Sierra, R., & Ochoa, A. C. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-1921 · Cited by 773
Disruption of CXCR2-Mediated MDSC Tumor Trafficking Enhances Anti-PD1 Efficacy
Highfill, S. L., Cui, Y., Giles, A. J., Smith, J. P., Zhang, H., Morse, E., Kaplan, R. N., & Mackall, C. L. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007974 · Cited by 767
A Controlled Trial of Sildenafil in Advanced Idiopathic Pulmonary Fibrosis
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002110 · Cited by 634
Cited by
Macrophages: versatile players in renal inflammation and fibrosis
Tang, P. M.-K., Nikolic-Paterson, D. J., & Lan, H.-Y. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0110-2 · Cited by 1,033
The Role of Immune and Inflammatory Cells in Idiopathic Pulmonary Fibrosis
Desai, O., Winkler, J., Minasyan, M., & Herzog, E. L. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00043 · Cited by 314
Self-citationPFKFB3-mediated endothelial glycolysis promotes pulmonary hypertension
Cao, Y., Zhang, X., Wang, L., Yang, Q., Ma, Q., Xu, J., Wang, J., Kovacs, L., Ayon, R. J., Liu, Z., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1821401116 · Cited by 213
The vascular perspective on acute and chronic lung disease
Borek, I., Birnhuber, A., Voelkel, N. F., Marsh, L. M., & Kwapiszewska, G. (2023) · Journal of Clinical Investigation · doi:10.1172/jci170502 · Cited by 103
Regulatory Immune Cells in Idiopathic Pulmonary Fibrosis: Friends or Foes?
van Geffen, C., Deißler, A., Quante, M., Renz, H. E., Hartl, D., & Kolahian, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.663203 · Cited by 88
Neutrophil‐T cell crosstalk and the control of the host inflammatory response
Bert, S., Nadkarni, S., & Perretti, M. (2022) · Immunological Reviews · doi:10.1111/imr.13162 · Cited by 71
Willis, G. R., Fernandez‐Gonzalez, A., Reis, M., Mitsialis, S. A., & Kourembanas, S. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092534 · Cited by 70
Targeting CXCR1 and CXCR2 receptors in cardiovascular diseases
Dhayni, K., Zibara, K., Issa, H., Kamel, S., & Bennis, Y. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108257 · Cited by 63
The role of chemokines and chemokine receptors in pulmonary arterial hypertension
Mamazhakypov, A., Viswanathan, G., Lawrie, A., SCHERMULY, R. T., & Rajagopal, S. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14826 · Cited by 60
Jandl, K., Marsh, L. M., Mutgan, A. C., Crnković, S., Valzano, F., Zabini, D., Hoffmann, J., Foris, V., Gschwandtner, E., Klepetko, W., et al. (2022) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202201-0142oc · Cited by 58
Idiopathic pulmonary fibrosis and pulmonary hypertension: Heracles meets the Hydra
Rajagopal, K., Bryant, A. J., Sahay, S., Wareing, N. E., Zhou, Y., Pandit, L. M., & Karmouty‐Quintana, H. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15036 · Cited by 50
Self-citationEvolving Perspectives on Innate Immune Mechanisms of IPF
Ishikawa, G., Liu, A., & Herzog, E. L. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.676569 · Cited by 45
Self-citationPi, L., Fu, C., Lu, Y., Zhou, J., Jorgensen, M., Shenoy, V., Lipson, K. E., Scott, E. W., & Bryant, A. J. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00138 · Cited by 34
Self-citationSun, X., Nakajima, E., Norbrun, C., Sorkhdini, P., Yang, A. X., Yang, D., Ventetuolo, C. E., Braza, J., Vang, A., Aliotta, J. M., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.159578 · Cited by 37
Pulmonary hypertension in patients with interstitial lung disease
Karampitsakos, Τ., Tzouvelekis, A., Chrysikos, S., Bouros, D. E., Tsangaris, I., & Fares, W. H. (2018) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2018.03.002 · Cited by 31
Role of myeloid-derived suppressor cells in tumor recurrence
Cole, K., Al-Kadhimi, Z. S., & Talmadge, J. E. (2023) · Cancer and Metastasis Reviews · doi:10.1007/s10555-023-10079-1 · Cited by 33
Loss of immune homeostasis in patients with idiopathic pulmonary arterial hypertension
Heukels, P., Corneth, O. B. J., van Uden, D., van Hulst, J. A. C., van den Toorn, L. M., van den Bosch, A. E., Wijsenbeek, M. S., Boomars, K. A., Kool, M., & Hendriks, R. W. (2021) · Thorax · doi:10.1136/thoraxjnl-2020-215460 · Cited by 28
Interpreting Immunoregulation in Lung Fibrosis: A New Branch of the Immune Model
Huaux, F. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.690375 · Cited by 31
Warheit-Niemi, H. I., Huizinga, G. P., Edwards, S. J., Wang, Y., Murray, S., O’Dwyer, D. N., & Moore, B. B. (2022) · ImmunoHorizons · doi:10.4049/immunohorizons.2200083 · Cited by 29
Oliveira, A. C. D. S., Fu, C., Lu, Y., Williams, M. A., Pi, L., Brantly, M., Ventetuolo, C. E., Raizada, M. K., Mehrad, B., Scott, E. W., et al. (2019) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00156.2019 · Cited by 25
Self-citationNon–Interferon-Dependent Role of STING Signaling in Pulmonary Hypertension
Pham, A. T., de Oliveira, A. C., Fu, C., Alves, M. D., Dupee, Z., Mukhsinova, L., Ebrahimi, E., Patel, H., Patel, R., Nguyen, A., et al. (2023) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.123.320121 · Cited by 22
Self-citationMyeloid-Derived Suppressor Cells Dampen Airway Inflammation Through Prostaglandin E2 Receptor 4
van Geffen, C., Deißler, A., Beer‐Hammer, S., Nürnberg, B., Handgretinger, R., Renz, H. E., Hartl, D., & Kolahian, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.695933 · Cited by 21
B7H3-dependent myeloid-derived suppressor cell recruitment and activation in pulmonary fibrosis
Liu, T., Santos, F. G. D. L., Rinke, A. E., Fang, C., Flaherty, K. R., & Phan, S. H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.901349 · Cited by 20
The immune mechanisms of acute exacerbations of idiopathic pulmonary fibrosis
Chen, T., Sun, W., & Xu, Z. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1450688 · Cited by 22
Emergency myelopoiesis contributes to immune cell exhaustion and pulmonary vascular remodelling
Fu, C., Lu, Y., Williams, M. A., Brantly, M., Ventetuolo, C. E., Morel, L. M., Mehrad, B., Scott, E. W., & Bryant, A. J. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14945 · Cited by 15
Self-citationDecoding the complexity: mechanistic insights into comorbidities in idiopathic pulmonary fibrosis
Selman, M., Buendia-Roldan, I., & Pardo, A. (2025) · European Respiratory Journal · doi:10.1183/13993003.02418-2024 · Cited by 20
Myeloid-derived suppressor cells and pulmonary hypertension
Zhang, H., Li, Q., Li, Y., Tang, X., Gu, L., & Liu, H. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1189195 · Cited by 13
Myeloid-Derived Suppressor Cells and Pulmonary Hypertension
Bryant, A. J., Mehrad, B., Brusko, T. M., West, J. D., & Moldawer, L. L. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082277 · Cited by 11
Self-citationA checkpoint on innate myeloid cells in pulmonary arterial hypertension
Bryant, A. J., Fu, C., Lu, Y., Brantly, M., Mehrad, B., Moldawer, L. L., Brusko, T. M., Brittain, E. L., West, J. D., Austin, E. D., et al. (2018) · Pulmonary Circulation · doi:10.1177/2045894018823528 · Cited by 9
Self-citationGeorge, P. M., & Mitchell, J. A. (2019) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00330.2019 · Cited by 9
Yin, Y.-Q., Peng, F., Situ, H.-J., Xie, J., Tan, L., Wei, J., Jiang, F., Zhang, S., & Liu, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1010345 · Cited by 10
Update in Pulmonary Vascular Disease 2016 and 2017
Brittain, E. L., Thennapan, T., Maron, B. A., Chan, S. Y., Austin, E. D., Spiekerkoetter, E. F., Bogaard, H. J., Guignabert, C., Paulin, R., Machado, R. F., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201801-0062up · Cited by 7
A wrinkle in time: circadian biology in pulmonary vascular health and disease
Bryant, A. J., Ebrahimi, E., Nguyen, A., Wolff, C. A., Gumz, M. L., Liu, A. C., & Esser, K. A. (2021) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00037.2021 · Cited by 7
Self-citationLopes, G. A. O., Lima, B. H. F., de Freitas, C. S., Peixoto, A. C., Soriani, F. M., Cassali, G. D., Ryffel, B., Teixeira, M. M., Machado, F. S., & Russo, R. C. (2024) · Immunity Inflammation and Disease · doi:10.1002/iid3.70042 · Cited by 3
The Third Man: DNA sensing as espionage in pulmonary vascular health and disease
Bryant, A. J., Pham, A. T., Gogoi, H., Mitchell, C. R., Pais, F. M., & Jin, L. (2021) · Pulmonary Circulation · doi:10.1177/2045894021996574 · Cited by 3
Self-citationde Moraes, L. H. O., Beling, T., Pimenta, G. F., & Bruder-Nascimento, T. (2025) · Clinical science · doi:10.1042/cs20257214 · Cited by 4
Myeloid-derived suppressor cells in metabolic and cardiovascular disorders
Yan, J., Guo, S., He, J., Huang, H. H., & Xu, Y. (2025) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2025.02.001 · Cited by 3
Opposing roles for myeloid and smooth muscle cell STING in pulmonary hypertension
Pham, A. T., Virk, S. T., Oliveira, A. C. D. S., Alves, M. D., Fu, C., Zhang, Y., Alvarez-Castanon, J. V., Lee, B. B., Lee, K., Mashina, R., et al. (2025) · JCI Insight · doi:10.1172/jci.insight.184792 · Cited by 2
Self-citationVedder, N., Gercke, P., Lautenschlager, N., Brunn, T., Lange, T., Schieb, J., Vetter, C., van Geffen, C., & Kolahian, S. (2025) · The FASEB Journal · doi:10.1096/fj.202500312rr · Cited by 2
Detection of myeloid-derived suppressor cells by flow cytometry
Liu, T., Rosek, A., Santos, F. G. D. L., & Phan, S. H. (2023) · Methods in cell biology · doi:10.1016/bs.mcb.2023.06.006 · Cited by 1
Durmuş, N., & Grünig, G. (2018) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2017-0336ed
Cell dichotomous role of STING in pulmonary hypertensionPreprint
Pham, A. T., Oliveira, A. C. D. S., Fu, C., Alves, M. D., Dupee, Z., Mukhsinova, L., Ebrahimi, E., Patel, H., Patel, R., Nguyen, A., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.11.29.518422
Self-citationPolishchuk, V., Pashevin, D. O., Dons’koi, B. V., Lapikova-Bryhinska, T., Portnichenko, G. V., Drevytska, T., Nagibin, V. S., & Dosenko, V. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04750-3
The role of myeloid-derived suppressor cells in Sjögren's disease
Jin, L., Yang, C., Gan, J., Wan, Z., Liu, Y., Wong, V. K. W., Li, C., & Wang, Y. (2026) · Autoimmunity Reviews · doi:10.1016/j.autrev.2026.104051
B7-H3 (CD276) regulates myeloid-derived suppressor cell differentiation in pulmonary fibrosis
Santos, F. G. D. L., Rosek, A., Ando, A., Phan, S. H., Mahadevan, N. R., & Liu, T. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1903767
TREM2 Orchestrates Myeloid Cell Programming and Immune Dysregulation in Pulmonary HypertensionPreprint
de Oliveira, A. C., da Silva, F., Zhang, Y., Alves, M. D., Pham, A. T., Harris, C. L., Khanfar, S., Abdelnor, R., Alvarez-Castanon, J. V., Philips, C. M., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.09.18.752808
Self-citationYokokawa, T., Ueda, S., Nishiura, K., Okochi, S., Ogawara, R., Kiko, T., Miura, S., Misaka, T., Oikawa, M., Masuishi, Y., et al. (2026) · Pulmonary Circulation · doi:10.1002/pul2.70446
Metadata
- Authors
- Bryant, A. J., Shenoy, V., Fu, C., Marek, G., Lorentsen, K. J., Herzog, E. L., Brantly, M. L., Avram, D., & Scott, E. W.
- Affiliations
- University of Florida (US)
- California Health Sciences University (US)
- Yale University (US)
- Corresponding author
- Bryant, Andrew J.
- ORCID
- Venue
- American Journal of Respiratory Cell and Molecular Biology
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-02-01
- Volume
- 58
- Issue
- 2
- Pages
- 170-180
- ISSN
- 1044-1549 (ISSN-L)
- 1535-4989
- PMC
- PMC5805999
- OpenAlex
- W2751016427
- Cited by
- 47
- References
- 70
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 2 · 2023: 5 · 2022: 8 · 2021: 7 · 2020: 1 · 2019: 6 · 2018: 8
- FWCI
- 3.39
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- American Journal of Respiratory Cell and Molecular Biology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (KL2TR001429)
- National Institute on Aging (P30AG028740)
- National Heart, Lung, and Blood Institute (R01HL109233)
- National Institute of Allergy and Infectious Diseases (R01AI067846, R21AI131205, T32AI007110)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK105916)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Keywords
- myeloid-derived suppressor cells, pulmonary hypertension, idiopathic pulmonary fibrosis, CXCR2, granulocytic MDSCs, clodronate liposomes, bleomycin-induced lung fibrosis, bone marrow-derived cells, chemokine receptor inhibition, pathogenesis
- MeSH terms
- Myeloid-Derived Suppressor Cells, Animals, Arginase, Bleomycin, Cell Movement, Clodronic Acid, Female, Hypertension, Pulmonary, Male, Mice, Inbred C57BL, Phenylurea Compounds, Interleukin-8, Myeloid Cells, Receptors, Interleukin-8B, Mice, Nitric Oxide Synthase Type II, Idiopathic Pulmonary Fibrosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.